
Explore recent advancements in blood cancer treatments, including targeted therapies, immunotherapies, and precision medicine approaches, with insights on their impact and potential for improved patient outcomes.

Explore CAR T-cell therapy for pediatric cancer: indications, care plans, side effects, risks, and benefits. Learn about this breakthrough cellular treatment from a UCLA expert.

Explore cutting-edge CAR T cell therapy for lymphoma with Dr. Sarah Larson. Learn about latest research, safety improvements, and potential breakthroughs in this innovative cancer treatment approach.

Explore quantitative modeling of CAR T cell activity against AML through in vitro cytolytic assays, enhancing understanding of immunotherapy effectiveness.

Explore advanced CAR T-cell therapy strategies for solid tumors, focusing on lateral architectures to overcome efficacy challenges in non-hematological cancers.

Explore novel CAR-T cell engineering using piggyBac transposon for solid tumors. Learn about memory-rich T cells, manufacturing processes, and potential clinical applications in cancer immunotherapy.

Explore immunological reset, B cell depletion, CAR T therapy, and precision immunotherapies for scleroderma treatment with expert insights on current and future approaches.

Explore cutting-edge gene therapy techniques CRISPR/Cas9 and CAR T-cell therapy, including recent FDA approval for sickle cell anemia treatment and potential applications for other genetic disorders.

Explore the potential of CAR-T cell therapies in treating autoimmune diseases, focusing on recent advancements and future opportunities for potentially curative approaches beyond oncology.

Explore upcoming CAR T-Cell therapy trials for Systemic Sclerosis, including benefits, criteria, and information sources with experts Dr. Khanna and Dr. Ghosh.

Pioneering immunologist Carl June discusses CAR T-cell therapy, a revolutionary cancer treatment that reprograms patients' immune cells to fight tumors, potentially transforming cancer care and offering hope for incurable cases.

Delve into the mechanisms of CAR T cell therapy resistance in lymphoma treatment, exploring tumor evasion, T-cell dysfunction, and innovative approaches to enhance therapeutic outcomes and reduce toxicity.

Every day, people die waiting for an organ that never comes. But what if replacement organs didn’t have to be donated; what if they could be grown? This talk explores how a 2500-year-old myth could serve as a blueprint for reengineering healthcare from the inside out. Misha is a Research Associate a